Harpoon Therapeutics Stock Price, News & Analysis
Company Description
Harpoon Therapeutics (NASDAQ: HARP) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.
HARP stock has declined 100.0% over the past year.
This page provides a comprehensive overview of HARP stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Harpoon Therapeutics (HARP) stock. Over the past 12 months, the stock has lost 100.0%.
Latest News
Harpoon Therapeutics has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include management, acquisition, clinical trial, earnings, private placement. View all HARP news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
HARP Company Profile & Sector Positioning
Harpoon Therapeutics (HARP) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.